Ask a site director whether their last study came in on budget and you will usually get a confident yes. Ask whether it made money and the answer gets slower. Those are different questions, and most research organizations have a system that answers the first one and nothing at all that answers the second.
Clinical trial budget management is normally taught as a negotiation skill. You price the protocol, benchmark the per patient cost, argue with the sponsor, sign. That is genuinely the hard part, and there is good software for it. What almost nobody covers is the half that happens afterwards, when the study is running and the hours are being spent and nothing in your stack is quietly adding them up.
This guide covers both halves, and it is honest about which tools do which. If you are choosing systems for a wider research stack, we have also mapped the eleven categories of clinical trial software and the best tool in each.
- What a clinical trial budget actually contains
- How budgets get built and negotiated
- The costs that never make it into the budget
- Clinical trial budget tracking: planned against actual
- Why staff time is the line nobody tracks
- Which tool covers which stage
- Tracking study cost and profitability with actiTIME
- Time documentation and federal awards
- Frequently asked questions
What a clinical trial budget actually contains
A trial budget has three layers, and confusing them is where the trouble starts.
Per patient costs. Everything that happens because a participant walked through the door: study visits, procedures, labs, imaging, stipends, travel reimbursement. These are the numbers sponsors negotiate hardest, and they scale with enrollment.
Fixed and overhead costs. Ethics committee and IRB fees, pharmacy setup, archiving, equipment, and the institutional overhead rate applied on top. They happen whether you enroll two participants or two hundred.
Staff time. Coordinator hours, investigator time, regulatory work, monitoring visit support, data entry, query resolution. This layer is the largest cost at most sites, and it is the one usually captured as a vague administrative percentage instead of a measured quantity.
The first two layers are countable in advance. The third is a guess until the study is over, which is precisely why studies that look profitable on paper often are not.
How budgets get built and negotiated
Budget construction has become a software category of its own, built around fair market value benchmarks so that neither side is arguing from a spreadsheet of gut feelings.
IQVIA CTFS GrantPlan uses benchmark data and fair market value principles to build study budgets and negotiate investigator grants, and IQVIA says it is used by 90 percent of top pharmaceutical companies. Medidata Clinical Trial Financial Management connects budgeting, site negotiation, and payments so financial decisions stay linked as a study changes. Suvoda’s budgeting and benchmarking offers fair market value data across more than 70 countries, refreshed quarterly. Trialytix calculates study costs from parameters such as patient and site counts, and lets teams simulate budget scenarios and amendments.
These are capable products aimed at a hard problem. Note what they have in common: all of them price the study before it runs. None of them watches what happens next.
The costs that never make it into the budget
Certain work is real, consumes staff hours, and is either unbilled or billed at a rate that never covered it. Every experienced coordinator can list these from memory.
- Screening participants who never enroll
- Preparing for and hosting monitoring visits
- Resolving data queries months after a visit
- Protocol amendments and re consenting
- Regulatory document upkeep between studies
- Chasing sponsors for payment
Screening is the clearest example, because the volume is far higher than most budgets assume. Data from the Tufts Center for the Study of Drug Development, reported in Applied Clinical Trials, put the overall average screen failure rate at 36.3 percent across therapeutic areas, up from 34.7 percent in 2012, and considerably higher in central nervous system studies.
In some settings it is far worse. An audit of 15 randomized studies at Tata Memorial Centre, published in ecancermedicalscience in 2022, screened 7,481 patients and enrolled 3,666 of them. The other 3,815, which is 51.0 percent, were screen failures. That audit is a single oncology center in India and its rate should not be read as a global average, but it makes the shape of the problem concrete: for every participant who enrolled, a second one consumed coordinator time and produced no enrollment revenue.
If your budget reimburses screen failures at all, it usually reimburses a fraction of them at a fraction of the visit cost. The gap is absorbed by staff hours that nobody counted.
Clinical trial budget tracking: planned against actual
Clinical trial budget tracking means one thing: comparing what you agreed to spend against what you actually spent, while there is still time to act on the difference.
Most sites do a version of this for procedures and invoices, because a CTMS handles it. Visits get logged, procedures trigger invoices, payments get reconciled. What a CTMS does not know is how many hours your coordinators spent producing those visits, or what those hours cost. So the tracking is partial. Revenue is measured precisely and the largest cost line is estimated.
A complete tracking loop needs four things: an agreed budget broken down to a level you can actually observe, recorded actuals against each element, a cost rate that turns hours into money, and a comparison you look at before the study ends instead of after.
The third of those is where most organizations stop. Hours are recorded in a timesheet somewhere, but the timesheet does not know what an hour of a senior coordinator’s time costs, so nothing multiplies out and nothing ever reaches the profit and loss.
Why staff time is the line nobody tracks
There is decent evidence that coordinator effort varies enough between studies to make averaging it dangerous. A 2024 study in the Journal of Clinical and Translational Research adapted a trial complexity scoring tool and found that workload differed significantly between federally funded and industry sponsored protocols, and that complexity scores predicted coordinator hours well enough to plan capacity from them.
Read that finding twice. It says the hours a protocol will consume are predictable, but only if you have measured hours on comparable protocols first. Sites that never record time against studies have no basis for the prediction, which means every new budget they negotiate rests on a number they made up.
It also means the intuition that some studies are dogs and some are gold is usually correct and almost never quantified. The coordinators know. The finance report does not.
Which tool covers which stage
Three categories of software touch trial money, and the boundaries between them are sharper than the marketing suggests.
| Stage | Question it answers | Tool category | Examples |
|---|---|---|---|
| Before the study | What should this protocol cost, and what should we charge? | Clinical trial budget software | IQVIA CTFS GrantPlan, Medidata CTFM, Suvoda, Trialytix |
| During the study | Which visits happened, what do we invoice, were we paid? | CTMS | Clinical Conductor, RealTime-CTMS, OnCore |
| During and after | What did the work cost us, and did this study make money? | Time and cost tracking | actiTIME |
A CTMS clinical trial budget module tracks the money the sponsor owes you. It does not track the money you spend earning it. That distinction is the whole argument of this article, and it is why sites running mature CTMS deployments still cannot say which studies are profitable.
Tracking study cost and profitability with actiTIME
actiTIME is time tracking software that turns recorded hours into cost, billable amounts, and margin. Be clear about the boundary: it does not build budgets, benchmark grants, or negotiate with sponsors, and it is not a regulated system of record. It covers the stage the budgeting tools leave alone.
Setting it up for research work takes four steps.
-
Map your work structure.
actiTIME organizes work as customer, then project, then task, and all three labels can be renamed. Most sites use sponsor, protocol, and visit or activity. Create tasks for the work that never appears in a budget: screening, monitoring visit support, query resolution, regulatory upkeep.
-
Set cost of work rates per person.
Each employee gets an hourly cost rate, with separate rates for overtime and leave. This is what converts a timesheet into money.
-
Set billing rates per type of work.
Billing rates attach to types of work, which attach to tasks. Recorded hours then produce a billable amount alongside the cost.
-
Set budgets and watch them.
Cost, billing, and time budgets can sit at the sponsor, protocol, or task level, each with a progress bar that turns red on overrun. This is where an amendment that doubled coordinator workload without anyone noticing becomes visible while the study is still running.
The reporting is what you are paying for. The Cost of Work report shows staff expense per protocol. The Billing Summary shows what is billable. The Profit/Loss report puts them side by side by sponsor, protocol, or task, which is the number that tells you whether to accept a similar study next year. Invoices generate as PDFs directly from billable time, and time entries can be locked once a period closes so clinical research billing does not have to be reconciled against a timesheet that keeps moving.
Pricing is public, which is unusual in this market. The cloud version starts at $5 per user each month, a permanent free version covers teams of up to three users, and academic centers with data residency obligations can run a self hosted installation on their own infrastructure for a one time payment of $120 per user.
If you run trials for sponsors, our guide on using actiTIME for contract research organizations covers the setup in more detail, and we have written separately about the challenges contract research organizations face.
Time documentation and federal awards
If any part of your research is funded by a federal award, time records stop being a management preference and become a compliance requirement. Under 2 CFR 200.430, charges to federal awards for salaries and wages must be based on records that accurately reflect the work performed.
This is the domain of time and effort reporting, and it is worth being precise about where a time tracker fits. actiTIME produces the underlying records and the reports that summarize hours by project and person. Formal effort certification, where a principal investigator attests that the distribution of effort is reasonable, belongs in your research administration system. Use the two together. Do not expect either to be the other.
Frequently asked questions
What is clinical trial budget management?
It is the practice of building a study budget, negotiating it with the sponsor, and then tracking actual spend against it while the study runs. Most organizations do the first two well and the third badly, because the tools that build budgets are not the tools that record what the work cost.
What is the difference between clinical trial budget software and a CTMS?
Budget software prices the protocol before it starts, using benchmark and fair market value data to set per patient costs and support negotiation. A CTMS runs the study operationally and tracks visits, procedures, invoices, and payments. Neither one measures the staff hours consumed producing that work, or converts those hours into a cost.
Why do studies that look profitable lose money?
Because the largest cost at most sites is staff time, and staff time is usually entered into the budget as an estimate and never measured afterwards. Unreimbursed screening, monitoring visit support, and query resolution then consume hours that no line item covers. The revenue side is tracked precisely and the cost side is guessed.
How do you calculate the true per patient cost of a study?
Take the direct per patient costs from the budget, then add the staff hours attributable to that participant multiplied by a cost of work rate, including the screening effort for participants who never enrolled. Sites that track hours against protocols can calculate this. Sites that do not are estimating.
Which tool should we use for clinical trial cost management?
It depends which stage is failing you. If your budgets are unrealistic, look at clinical trial budget software with fair market value benchmarks. If invoices and payments are the problem, that is a CTMS. If you cannot say what a study cost or whether it was profitable, you need time and cost tracking alongside both.
Getting started
Pick one active protocol and track hours against it for a quarter. Set a cost rate per person, create tasks for screening and monitoring support, and run the Profit/Loss report at the end. Most sites are surprised, and the surprise is the point, because the same number tells you what to charge for the next study.
Learn how to set up time tracking in five steps, or start with the permanent free version for up to 3 users or run a full-featured 30-day trial at no cost.
